[HTML][HTML] Thyroid diseases and breast cancer

E Baldini, A Lauro, D Tripodi, D Pironi… - Journal of Personalized …, 2022 - mdpi.com
Background: Open Access Editor's Choice Review Thyroid Diseases and Breast Cancer by
Enke Baldini 1, Augusto Lauro 1, Domenico Tripodi 1, Daniele Pironi 1, Maria Ida Amabile 1 …

Benign thyroid disease and the risk of breast cancer: An updated systematic review and meta-analysis

M Han, Y Wang, Y Jin, X Zhao, H Cui… - Frontiers in …, 2022 - frontiersin.org
Background The correlation between benign thyroid disease (BTD) and breast cancer (BC)
has long been discussed. However, the definite relationship and potential mechanism …

The TSH/thyroid hormones axis and breast cancer

IA Voutsadakis - Journal of Clinical Medicine, 2022 - mdpi.com
Breast cancer, the most prevalent female carcinoma, is characterized by the expression of
steroid nuclear receptors in a subset of cases. The most important nuclear receptor with …

Hypothyroidism induces oxidative stress and DNA damage in breast

MS Peixoto, AV e Souza, IS Andrade… - Endocrine-Related …, 2021 - erc.bioscientifica.com
Breast cancer and thyroid dysfunctions have been associated for decades. Although many
studies suggest a biological correlation, the mechanisms linking these two pathologies have …

Development of histologically verified thyroid diseases in women operated for breast cancer: a review of the literature and a case series

F Fama', A Sindoni, H Sun, HY Kim, G Geraci… - Journal of Clinical …, 2022 - mdpi.com
Background: The possible relationships between breast and thyroid diseases have been
reported in the literature. The purpose of our study was to evaluate the occurrence of …

[HTML][HTML] PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth

MN Campos Haedo, JA Díaz Albuja… - International Journal of …, 2024 - mdpi.com
Thyroid carcinoma (TC) is the most common endocrine neoplasia, with its incidence
increasing in the last 40 years worldwide. The determination of genetic and/or protein …

Tyrosine kinase inhibitor–induced hypothyroidism: mechanism and clinical implications

Z Wang, H Wang, C Bu, B Meng, Y Mu, S Gao… - European Journal of …, 2024 - Springer
Introduction Since the first experimentally proven tyrosine kinase inhibitor (TKI) imatinib was
introduced in the clinical setting, TKIs have attracted widespread attention because of their …

Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells

MJP Valenzuela Alvarez, LM Gutierrez, JM Bayo… - Molecular Biology …, 2024 - Springer
Background Osteosarcoma (OS) stands out as the most common bone tumor, with
approximately 20% of the patients receiving a diagnosis of metastatic OS at their initial …

Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro

O Rostkowska, A Olejniczak-Kęder… - Oncology …, 2022 - spandidos-publications.com
Cancer stem cells (CSCs) play a key role in the development and progression of colorectal
cancer (CRC), but the influence of triiodothyronine (T3) on the biological regulation of CSCs …

Thyroid Hormones Shape the Fate of Cancer Cells and Antitumor Immune Responses

HA Sterle, F Cayrol, GA Cremaschi - Handbook of Cancer and …, 2023 - Springer
The activation of the innate and the adaptive immune responses contributes to the control
and eradication of tumors. Natural killer cells and T lymphocytes have a crucial role in tumor …